Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis

Shah, Svati H., Freedman, Neil J., Zhang, Lisheng, Crosslin, David R., Stone, David H., Haynes, Carol, Johnson, Jessica, Nelson, Sarah, Wang, Liyong, Connelly, Jessica J., Muehlbauer, Michael, Ginsburg, Geoffrey S., Crossman, David C., Jones, Christopher J. H., Vance, Jeffery, Sketch, Michael H., Granger, Christopher B., Newgard, Christopher B., Gregory, Simon G., Goldschmidt-Clermont, Pascal J., Kraus, William E. and Hauser, Elizabeth R. (2009) Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genetics, 5 (1). ISSN 1553-7404

Full text not available from this repository.

Abstract

Neuropeptide Y (NPY) is a strong candidate gene for coronary artery disease (CAD). We have previously identified genetic linkage to familial CAD in the genomic region of NPY. We performed follow-up genetic, biostatistical, and functional analysis of NPY in early-onset CAD. In familial CAD (GENECARD, N = 420 families), we found increased microsatellite linkage to chromosome 7p14 (OSA LOD = 4.2, p = 0.004) in 97 earliest age-of-onset families. Tagged NPY SNPs demonstrated linkage to CAD of a 6-SNP block (LOD = 1.58–2.72), family-based association of this block with CAD (p = 0.02), and stronger linkage to CAD in the earliest age-of-onset families. Association of this 6-SNP block with CAD was validated in: (a) 556 non-familial early-onset CAD cases and 256 controls (OR 1.46–1.65, p = 0.01–0.05), showing stronger association in youngest cases (OR 1.84–2.20, p = 0.0004–0.09); and (b) GENECARD probands versus non-familial controls (OR 1.79–2.06, p = 0.003–0.02). A promoter SNP (rs16147) within this 6-SNP block was associated with higher plasma NPY levels (p = 0.04). To assess a causal role of NPY in atherosclerosis, we applied the NPY1-receptor–antagonist BIBP-3226 adventitially to endothelium-denuded carotid arteries of apolipoprotein E-deficient mice; treatment reduced atherosclerotic neointimal area by 50% (p = 0.03). Thus, NPY variants associate with atherosclerosis in two independent datasets (with strong age-of-onset effects) and show allele-specific expression with NPY levels, while NPY receptor antagonism reduces atherosclerosis in mice. We conclude that NPY contributes to atherosclerosis pathogenesis.

Item Type:	Article
Additional Information:	© 2009 Shah et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit
Depositing User:	Rhiannon Harvey
Date Deposited:	09 May 2011 12:22
Last Modified:	23 Oct 2022 05:32
URI:	https://ueaeprints.uea.ac.uk/id/eprint/30026
DOI:	10.1371/journal.pgen.1000318

Actions (login required)

View Item